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Abstract
Background: Prior investigations have not identified a major locus for vertebral malformations,
providing evidence that there is genetic heterogeneity for this condition. WNT3A has recently been
identified as a negative regulator of Notch signaling and somitogenesis. Mice with mutations in
Wnt3a  develop caudal vertebral malformations. Because congenital vertebral malformations
represent a sporadic occurrence, linkage approaches to identify genes associated with human
vertebral development are not feasible. We hypothesized that WNT3A mutations might account
for a subset of congenital vertebral malformations.
Methods: A pilot study was performed using a cohort of patients with congenital vertebral
malformations spanning the entire vertebral column was characterized. DNA sequence analysis of
the WNT3A gene in these 50 patients with congenital vertebral malformations was performed.
Results: A female patient of African ancestry with congenital scoliosis and a T12-L1 hemivertebrae
was found to be heterozygous for a missense variant resulting in the substitution of alanine by
threonine at codon 134 in highly conserved exon 3 of the WNT3A gene. This variant was found at
a very low prevalence (0.35%) in a control population of 443 anonymized subjects and 1.1% in an
African population.
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Conclusion: These data suggest that WNT3A does not contribute towards the development of
congenital vertebral malformations. Factors such as phenotypic and genetic heterogeneity may
underlie our inability to detect mutations in WNT3A in our patient sample.
Background
Congenital vertebral malformations are phenotypically
and etiologically heterogeneous. Their estimated inci-
dence is between 0.5 to 1/1000 [1-4]. Vertebral malforma-
tions may represent an isolated finding, occur in
association with other renal, cardiac, or spinal cord mal-
formations, or occur as part of an underlying chromo-
some abnormality or syndrome. These include, but are
not limited to, hemifacial microsomia, Alagille, Jarcho-
Levin, Klippel-Feil, Goldenhar,, basal cell nevus, trisomy
18, diabetic embryopathy and VACTERL (vertebral, car-
diac, renal, limb anomalies, anal atresia, tracheo-esopha-
geal fistula) syndromes. Vertebral malformations most
commonly include hemivertebrae, vertebral bars, super-
numerary vertebrae, butterfly vertebrae, and wedge-
shaped vertebrae.
Congenital scoliosis is caused by segmentation defects
such as fused vertebrae, vertebral body formation defects,
and mixed defects in which both types of lesions are
encountered [3,4]. Each of these conditions may cause
development of a spinal curve based on asymmetric
growth. The severity of the curve is related to the type of
defect and whether or not the primary problem is accom-
panied by any compensatory developmental changes.
Vertebral segmentation proceeds through a clock and
wave front mechanism under Notch signaling control.
Negative feedback through the canonical Wnt/β catenin
pathway via Axin 2 modulates the process [5,6]. Based on
mouse-human synteny analysis, a series of candidate
genes known to cause vertebral malformations in the
mouse have been identified [5-8]. One gene, Wnt3a, is
necessary for generation of the posterior portion of the
neuraxis, as knockout mice fail to develop a tailbud and
are truncated from a point slightly anterior to the hind-
limbs [9]. This gene is a member of a moderate-sized mul-
tigene family comprised of at least 12 members in
humans and the mouse. Genes in this family function
both in establishing the body plan in development and as
potential oncogenes [10]. Wnt3a has been proposed to be
a major controlling gene in the oscillation of Notch sign-
aling that is necessary for segmentation to occur [5].
Since isolated congenital vertebral malformation most
often represents a sporadic occurrence within a particular
family, it is virtually impossible to utilize traditional link-
age approaches to identify causative genes. This makes
candidate gene analyses a viable alternative method to
study this condition. We hypothesized that mutations in
WNT3A may be associated with the development of iso-
lated vertebral malformations and congenital scoliosis. In
order to test this hypothesis we undertook a pilot study
and performed DNA sequence analysis in a heterogene-
ous cohort of 50 patients with congenital vertebral mal-
formations.
Methods
Vertebral malformation subjects
Fifty children and adults with radiographic evidence for
congenital segmental vertebral malformations were iden-
tified from the orthopedics and clinical genetic practices
at Marshfield Clinic, Marshfield, Wisconsin, the Pediatric
Orthopedics Department at the Hospital for Special Sur-
gery, New York, New York, and the Bone Dysplasia Clinic
at the University of Wisconsin, Madison.
Medical records of each patient were reviewed to deter-
mine if cardiac, renal, or spinal cord malformations were
previously identified. Blood samples or buccal swabs were
obtained from index cases (probands) and parents (when
available) for subsequent DNA analysis. Five tissue sam-
ples were obtained from stillborn infants through the Wis-
consin Stillbirth Program. Subjects' vertebral
malformations were classified as previously described
[11].
Mutational Analysis
Genomic DNA was amplified and the products were puri-
fied using the QIAquick PCR purification kit (QIAGEN,
Inc., Valencia, California) and sequenced using either uni-
directional or bi-directional di-deoxy sequencing with the
DYEnamic ET Terminator Cycle Sequencing Kit (Amer-
sham Biosciences Corp., Piscataway, New Jersey) on the
PRISM 3100 Genetic Analyzer (Applied Biosystems, Fos-
ter City, California). Sequence analysis was performed
using DNASTAR software (DNASTAR, Madison, Wiscon-
sin). The same primers were used for amplification and
sequencing. Primers and product sizes are shown in Table
1.
DNA sequence variants identified in subjects with verte-
bral malformations were compared to the UCSC golden-
Path May 2004 sequence assembly [12].
Allele frequencies were determined in the control popula-
tion using the homogeneous mass extend reaction and the
matrix-assisted laser desorption/ionization time-of-flightScoliosis 2007, 2:13 http://www.scoliosisjournal.com/content/2/1/13
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mass spectrophotometer (Sequenom) [13]. A panel of
443 subjects (360 of whom were from the CEPH diversity
panel) was tested for the WNT3A variant. The panel con-
sisted of 126 subjects from African ancestry, 299 were
Caucasians, 12 were Oceanic, and 6 were Asians. A panel
of 23 anonymized DNA samples was used to determine
the frequency of the WNT3A  C/G promoter polymor-
phism, respectively.
Results
Vertebral malformations were classified as butterfly verte-
bra, segmentation defect, or hemivertebra/hypoplasia.
The vertebral malformations spanned the length of the
entire spine and were classified as butterfly vertebrae, seg-
mentation defect, hypoplasia and hemivertebrae [4]. But-
terfly vertebrae were defined by the presence of a sagittal
cleft. Segmentation defects include defects arising from
intervertebral discs such as block vertebrae and unseg-
mented vertebral bars. The vertebral malformations
spanned the length of the entire spine and are illustrated
(figure 1). The malformation characteristics of the study
sample are highlighted in Table 2.
To analyze the WNT3A gene in the selected vertebral mal-
formation cohort, a total of four segments in the WNT3A
gene were amplified and sequenced in each patient. The
sequencing covered the four exonic regions, splice junc-
tions, and 381 bp of the promoter region. A 23-month-
old female child of Cape Verde African ancestry with an
isolated T12-L1 hemivertebrae and congenital scoliosis
with a 38° lumbar scoliotic curve was found to be hetero-
zygous for a GCC to ACC missense variant at codon 134
(UCSC position chr1:224,545,178 May 2004 assembly)
of the WNT3A gene (figure 2), resulting in the substitu-
tion of alanine by threonine. The patient's clinically
asymptomatic father was also heterozygous for the mis-
sense variant, whereas her mother was not. This exon is
highly conserved, whereas codon 134 is less conserved in
this exon. Interestingly, the alanine amino acid at codon
134 is conserved in mouse, rat, dog and opossum,
whereas in elephant, chicken, Xenopus tropicalis and tetra-
don, alanine is replaced by threonine. To check for the
prevalence of this variant in reference population, a total
of 890 chromosomes from 445 subjects were tested for
the WNT3A mutation, of which 133 were of African ori-
gin, 299 were Caucasians, and 11 were Asians. Only three
subjects of African origin (Yoruba, Mbuti, and Bantu N.E.)
were heterozygous for the variant. The overall prevalence
of the variant in the tested reference population is 0.35%.
Moreover, a novel C/G single nucleotide variant was also
found in the promoter region of the WNT3A gene (UCSC
position chr1:224,501,511 May 2004 assembly). The
patient cohort had an average heterozygosity of 0.130 and
allele frequencies of 0.93 and 0.07 for the C and G alleles,
respectively. In order to determine the significance of this
variant, we typed a panel of 23 anonymized reference
DNA samples of Caucasian ancestry. The average hetero-
zygosity for this variant in the reference cohort was calcu-
lated to be 0.159 and the allele frequencies were 0.91 and
0.09 for the C and G alleles, respectively. The genotype
distribution for this variant did not differ significantly
between the patient's and reference cohorts (Chi-squared
= 0.001, p-value = 0.97) and were in Hardy-Weinberg
equilibrium in both cohorts. We conclude that this vari-
ant likely represents a polymorphism.
Discussion
In a series of 50 patients with a broad array of vertebral
malformations encompassing the entire length of the spi-
Table 1: Primers and corresponding product sizes
Primer Sequence Length Product size (bp)
WT-P-E1(F2) CAGCACGTCCTCAGACACAC 20 581
WT-P-E1(R2) CCGTCAAGGAAAACCAACC 19
WTE2(F) TAGCCTGCTCATCTGTGTCG 20 367
WTE2(R) GCTAGGCGGGAGACTCTGT 19
WTE3(F) AATGGGCTAAGACCCCTGAC 20 390
WTE3(R) GAGGCTCCTTTTTCCCAAG 19
WTE4(F) CAGGCGACATGTAATGCTGT 20 644
WTE4(R) TTTAGGTGGGAGTCCTGCTC 20
• WNTE3Mut(F) ACGTTGGATGACACGCTCATGTGCAGAAGG 30 94
• WNTE3Mut(R) ACGTTGGATGTACAGCCACCCCACTTCCAG 30
• WNTE3Mut(UE) TGTGCAGAAGGCACGGCC 18
• WNT-pr(F) ACGTTGGATGTATCCGAGTGGGGCCATCGC 30 98
• WNT-pr(R) ACGTTGGATGCGCCAGCTCCCAGGGCCCG 29
• WNT-pr(UE) CCGAGAGCGTGAGCGCC 17
The amplification and extension primers used in the homogeneous mass extend reaction are bulleted. The 10-mer tag used that increases the mass 
of the amplification primers so that they would fall outside the mass spectrophotometer range of analysis are bolded. UE denotes the unextended 
primers used in the mass extend reaction.Scoliosis 2007, 2:13 http://www.scoliosisjournal.com/content/2/1/13
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nal column, we only identified a non-synonymous vari-
ant in exon 3 of WNT3A, resulting in substitution of
alanine for threonine. Our observation of this variant
with an overall frequency of 0.35% in the control popula-
tion studied, and a frequency of 1.1% of African chromo-
somes included in the control population suggest and the
observation that the patient's clinically asymptomatic
father harbors the same variant strongly suggest that this
variant may represent a polymorphism in the African pop-
ulation. Based on the data obtained from our pilot study,
mutations in the WNT3A gene do not appear to be a com-
mon etiologic factor in the development of congenital
vertebral malformations.
Relative occurrence of vertebral malformations by spinal level and type Figure 1
Relative occurrence of vertebral malformations by spinal level and type.
Table 2: Malformation characteristics of study sample (n = 50)
Category of diagnosis of vertebral malformation Number
Isolated vertebral malformation(s) 15
Multiple congenital anomalies 11
VACTERL syndrome 9
Klippel-Feil syndrome 8
Facio-auriculo-vertebral spectrum and Goldenhar 3
Jugulolymphatic obstruction sequence 1
Sacral agenesis 1
Spondylothoracic dysplasia 1
Spondylocostal dysostosis 1Scoliosis 2007, 2:13 http://www.scoliosisjournal.com/content/2/1/13
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Patient heterogeneity for vertebral malformations and
heterogeneity of candidate genes represent major limita-
tions in genetic analyses. It is possible that mutations in
WNT3A would have been identified if we had sequenced
a cohort of patients characterized by having caudal verte-
bral malformation phenotypes. Because congenital verte-
bral malformations represent a rare condition, collection
of a phenotypically homogeneous sample is not practical
and would require a greater amount of time. DNA
sequence analysis was limited to the WNT3A promotor,
exons, and intron-exon boundaries. Sequence variants in
the introns that could potentially contribute to abnormal
transcription would not have been detected. Copy
number variations in WNT3A will not have been detected
by this methodology. Other genes that regulate the expres-
sion of WNT3A have not been examined.
Evidence for genetically heterogeneous etiologies of verte-
bral malformations includes the identification of muta-
tions in DLL3 in patients with spondylocostal dysostosis
[14,15] and mutations identified in JAG 1 in patients with
Alagille syndrome [16]. Recently, a few DNA coding
sequence alterations with uncertain clinical significance
in PAX1 and DLL3 have been identified in a cohort of
patients with phenotypically characterized vertebral mal-
formations [17-20]. Our inability to detect mutations in
WNT3A, as well as other candidate genes studied, may
reflect differences in the regulation of somitogenesis in
humans as compared to mice. It is possible that mutations
in WNT3A are lethal in humans. Although our pilot study
included 5 stillbirth samples and no mutations in WNT3A
were detected, a larger cohort of stillbirth samples with
vertebral malformations would be needed to determine
whether mutations in WNT3A are prevalent among still-
births with congenital vertebral malformations. Tissue
mosaicism for a specific mutation and/or epigenetic fac-
tors may have an influence in the development of verte-
bral malformations in humans. Vertebral malformations
may have greater environmental components than genetic
components to their origin. A relationship between
abnormal distribution of the intersegmental arteries and
vertebral malformations was observed in 4 of 11 human
embryos and fetuses with congenital vertebral malforma-
tions, suggesting the possibility that abnormalities in vas-
cularization during the resegmentation process may
contribute towards the development of congenital verte-
bral malformations [21].
Clinical relevance in identifying mutations associated
with the development of vertebral malformations and
congenital scoliosis is to develop a molecular classifica-
tion system that could provide prognostic information
regarding the severity of progression of congenital scolio-
sis and the presence of associated birth defects to practi-
tioners and families. Although congenital scoliosis and
idiopathic scoliosis represent dichotomous processes,
namely a failure to develop normal vertebral structures for
the former and a failure to lose normal vertebral structures
for the latter, there is evidence that similar genetic factors
may play a role in both conditions [22]. Identification of
gene mutations which are associated with the develop-
ment of congenital scoliosis may also help improve our
understanding of the pathogenesis of idiopathic scoliosis.
In summary, we have been unable to detect mutations in
the WNT3A gene in a pilot study of 50 patients with ver-
tebral malformations encompassing the entire spine. This
study illustrates the problems posed by attempting to
design studies aimed at identification of patterning genes
contributing towards the development of vertebral mal-
formations. Future studies aimed at investigating the eti-
ology of congenital vertebral malformations should be
aimed at the study of additional candidate genes in a
more homogeneous patient population.
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